Corpus Intelligence IC Memo — NATIONWIDE CHILDRENS HOSP TOLEDO LLC 2026-04-26 15:51 UTC
IC Memo — NATIONWIDE CHILDRENS HOSP TOLEDO LLC
Investment Committee Memorandum | OH | 41 beds | Grade D | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NATIONWIDE CHILDRENS HOSP TOLEDO LLC

CCN 363309 | nan, OH | 41 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

NATIONWIDE CHILDRENS HOSP TOLEDO LLC is a 41-bed community hospital in nan, OH with $44.7M in net patient revenue and a 28.0% operating margin. The hospital serves a payer mix of 0.0% Medicare, 9.0% Medicaid, and 91.0% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.0% to 35.4% (+736bps).

Net Revenue HCRIS$44.7M
Current EBITDA COMPUTED$12.5M
Operating Margin COMPUTED28.0%
Occupancy HCRIS68.0%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS21.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
110
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 28.0% places it above the state median. Among 110 size-comparable peers (20-82 beds), the median margin is -1.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-82), prioritizing same-state peers. 110 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NATIONWIDE CHILDRENS HOSP TOLE (Target)OH41$44.7M28.0%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$939K+210bp18mo
Cost to Collect4.5%2.5%$894K+200bp12mo
Denial Rate Reduction12.0%6.5%$886K+198bp12mo
A/R Days Reduction5200.0%3800.0%$544K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$939K
Cost to Collect
$894K
Denial Rate Reduction
$886K
A/R Days Reduction
$544K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.3M
Current EBITDA$12.5M
+ RCM Uplift+$3.3M
Pro Forma EBITDA$15.8M
Current Margin28.0%
Pro Forma Margin35.4%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$19.3M$115.6M5.99x43.1%
Base (11x exit)10.0x11.0x$19.3M$133.5M6.92x47.2%
Bull Case9.0x11.0x$17.4M$150.6M8.67x54.0%
Bull (12x exit)9.0x12.0x$17.4M$169.4M9.76x57.7%
Bear Case11.0x10.0x$21.2M$92.9M4.38x34.4%
Bear (11x exit)11.0x11.0x$21.2M$109.1M5.14x38.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 110 hospitals with 20-82 beds
  • Same-state prioritization (n=111)
  • Comp margins: P25=-13.3% / P50=-1.8% / P75=10.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.